Cara Therapeutics Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Cara Therapeutics (CARA) Tops Q4 EPS by 6c
May 12, 2015 4:02 PM EDTCara Therapeutics (NASDAQ: CARA) reported Q4 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.
... More